Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 503 publications
Post-TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS Placement.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 19, 2026
A plain language summary of the CheckMate 9DW study: nivolumab in combination with ipilimumab for unresectable hepatocellular carcinoma (advanced liver cancer).
Journal: Future oncology (London, England)
Published: April 15, 2026
Erratum to 'BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update' [J Hepatol (2026) 631-654].
Journal: Journal of hepatology
Published: April 05, 2026
EORTC-1607-GITCG/ABC-09: Open-label first-line, single-arm phase II study of CisGem combined with pembrolizumab in patients with advanced or metastatic biliary tract cancer.
Journal: Translational oncology
Published: March 28, 2026
Long-term follow-up of a phase 1/2 trial of anti-GDF-15 antibody visugromab plus anti-PD-1 antibody nivolumab in anti-PD-1/-L1 relapsed/refractory solid tumors.
Journal: Journal of hematology & oncology
Published: March 25, 2026
Adding Estimates of Central Venous Pressure Boosts the Performance of Non-Invasive Assessment of the Portosystemic Gradient Prior to TIPS Implantation.
Journal: Diagnostics (Basel, Switzerland)
Published: March 10, 2026
Predicting Decompensation in Unresectable Hepatocellular Carcinoma on Atezolizumab Plus Bevacizumab: The ARTE Score.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 13, 2026
Update on Nivolumab Plus Ipilimumab Combination Therapy for Patients With Hepatocellular Carcinoma.
Journal: Gastroenterology & hepatology
Published: February 02, 2026
Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 28, 2025
Immune biomarkers predicting response to G-CSF in acute-on-chronic liver failure: results from a GRAFT trial sub-study.
Journal: Hepatology international
Published: November 14, 2025
TGF-β1 and TGF-β2 family members differentially modulate tumor initiation and invasiveness of primary liver cancer in a MMP14-dependent manner.
Journal: Carcinogenesis
Published: October 24, 2025
Treatments for unresectable hepatocellular carcinoma: insights from CheckMate 9DW - Authors' reply.
Journal: Lancet (London, England)
Published: October 01, 2025
Last Updated: 09/26/2026